Speaker illustration

Doctor Leslee Shaw

Icahn School of Medicine at Mount Sinai, New York (United States of America)

CT and nuclear: ESC vs. ACC/AHA Guidelines on stable chest pain

Event: EACVI 2023

Topic: Imaging of Coronary Artery Disease

Session type: Guidelines in Practice

Thumbnail

Great Debate: coronary CT angiography should be the first line investigation in a patient over 70 years with suspected angina

Event: ESC Congress 2022

Topic: Cardiac Computed Tomography (CT)

Session type: Great Debates

Thumbnail

Macrovascular versus microvascular involvements in coronary artery diseases by MMI

Event: ESC Congress 2022

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session type: Moderated ePosters

Thumbnail

Coronary calcium: new aspects in quantification and use in clinical routine

Event: ESC Congress 2022

Topic: Coronary Calcium

Session type: Moderated ePosters

Thumbnail

Multimodality imaging in coronary artery disease

Event: ESC Congress 2022

Topic: Imaging of Coronary Artery Disease

Session type: Abstract Sessions

Thumbnail

Great Debate: post-ISCHEMIA and SCOT-HEART – anatomy is all we need for risk stratification and treatment

Event: ESC Congress 2021 - The Digital Experience

Topic: Nuclear Imaging

Session type: Great Debates

Thumbnail

Present & Future of cardiac Computed Tomography

Event: ESC Congress 2019

Topic: Coronary Computed Tomography Angiography (Coronary CTA, CCTA)

Session type: Moderated Posters

Thumbnail

How to perform functional assessment of CAD with CT?

Event: ICNC 2019

Topic: Cardiac Computed Tomography (CT)

Session type: Symposium

Thumbnail

Lessons from cardiac imaging trials and unmet needs

Event: ICNC 2019

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session type: Symposium

Thumbnail

Asymptomatic coronary atherosclerosis - Can we improve the prediction of clinical events?

Event: ICNC 2019

Topic: Cross-Modality and Multi-Modality Imaging Topics

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb